GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia
scientific article published on 27 August 2018
Author/s
author: Joëlle A Pasman, Sven Stringer, Sandra Sanchez-Roige, Michel G. Nivard, Jue Sheng Ong, Hill F Ip, Matthijs D VAN DER Zee, Meike Bartels, Felix R. Day, Lea Karatheodoris Davis, James MacKillop, Jaime Derringer, Grant W. Montgomery, Albertine J Oldehinkel, Josep Antoni Ramos-Quiroga, Marta Ribasés, Jaakko Kaprio, Marco Boks, Jordana T. Bell, Joel Gelernter, Stuart Macgregor, Abraham A. Palmer, Danielle Posthuma, Marcus R. Munafò, Eske M Derks, Jacqueline M Vink, Dorret I. Boomsma, Tomáš Paus, Tim Spector, Karin J. H. Verweij, Abdel Abdellaoui, Nick Martin, Nathan A Gillespie, Sarah L Elson, Catharina A Hartman, Andrew C. Heath, Pamela A F Madden, Bart Baselmans, Harriet de Wit, Zachary F Gerring, Jorien L Treur, 23andMe Research Team, Substance Use Disorders Working Group of the Psychiatric Genomics Consortium, International Cannabis Consortium, Susan Branje, Pol A C van Lier, Reedik Mägi, Wim H J Meeus, Zdenka Pausova, John R. B. Perry
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.